Literature DB >> 33595723

A surrogate FRAX model for Pakistan.

G Naureen1, H Johansson2,3, R Iqbal4, L Jafri5, A H Khan5, M Umer6, E Liu2, L Vandenput2,7, M Lorentzon2,8, N C Harvey9,10, E V McCloskey3,11, J A Kanis12,13.   

Abstract

A surrogate FRAX® model for Pakistan has been constructed using age-specific hip fracture rates for Indians living in Singapore and age-specific mortality rates from Pakistan.
INTRODUCTION: FRAX models are frequently requested for countries with little or no data on the incidence of hip fracture. In such circumstances, the International Society for Clinical Densitometry and International Osteoporosis Foundation have recommended the development of a surrogate FRAX model, based on country-specific mortality data but using fracture data from a country, usually within the region, where fracture rates are considered to be representative of the index country.
OBJECTIVE: This paper describes the development and characteristics of a surrogate FRAX model for Pakistan.
METHODS: The FRAX model used the ethnic-specific incidence of hip fracture in Indian men and women living in Singapore, combined with the death risk for Pakistan.
RESULTS: The surrogate model gave somewhat lower 10-year fracture probabilities for men and women at all ages compared to the model for Indians from Singapore, reflecting a higher mortality risk in Pakistan. There were very close correlations in fracture probabilities between the surrogate and authentic models (r ≥ 0.998) so that the use of the Pakistan model had little impact on the rank order of risk. It was estimated that 36,524 hip fractures arose in 2015 in individuals over the age of 50 years in Pakistan, with a predicted increase by 214% to 114,820 in 2050.
CONCLUSION: The surrogate FRAX model for Pakistan provides an opportunity to determine fracture probability within the Pakistan population and help guide decisions about treatment.

Entities:  

Keywords:  Epidemiology; FRAX; Fracture probability; Hip fracture; Pakistan; Singaporean Indians; Surrogate

Mesh:

Year:  2021        PMID: 33595723      PMCID: PMC7889560          DOI: 10.1007/s11657-021-00894-w

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  30 in total

1.  FRAX-based intervention and assessment thresholds in seven Latin American countries.

Authors:  P Clark; E Denova-Gutiérrez; C Zerbini; A Sanchez; O Messina; J J Jaller; C Campusano; C H Orces; G Riera; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2017-12-23       Impact factor: 4.507

2.  Age- and gender-specific rate of fractures in Australia: a population-based study.

Authors:  K M Sanders; E Seeman; A M Ugoni; J A Pasco; T J Martin; B Skoric; G C Nicholson; M A Kotowicz
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

3.  FRAX-based intervention and assessment thresholds for osteoporosis in Iran.

Authors:  P Khashayar; A Keshtkar; A Ostovar; B Larijani; H Johansson; N C Harvey; M Lorentzon; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2019-08-01       Impact factor: 4.507

4.  FRAX assessment of osteoporotic fracture probability in Switzerland.

Authors:  K Lippuner; H Johansson; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2009-06-11       Impact factor: 4.507

5.  Major osteoporotic to hip fracture ratios in canadian men and women with Swedish comparisons: a population-based analysis.

Authors:  Anna Lam; William D Leslie; Lisa M Lix; Marina Yogendran; Suzanne N Morin; Sumit R Majumdar
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

6.  Sri Lankan FRAX model and country-specific intervention thresholds.

Authors:  Sarath Lekamwasam
Journal:  Arch Osteoporos       Date:  2013-08-22       Impact factor: 2.617

Review 7.  A systematic review of hip fracture incidence and probability of fracture worldwide.

Authors:  J A Kanis; A Odén; E V McCloskey; H Johansson; D A Wahl; C Cooper
Journal:  Osteoporos Int       Date:  2012-03-15       Impact factor: 4.507

8.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  J Compston; A Cooper; C Cooper; N Gittoes; C Gregson; N Harvey; S Hope; J A Kanis; E V McCloskey; K E S Poole; D M Reid; P Selby; F Thompson; A Thurston; N Vine
Journal:  Arch Osteoporos       Date:  2017-04-19       Impact factor: 2.617

9.  Utility of FRAX (fracture risk assessment tool) in primary care and family practice setting in India.

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Thomas Vizhalil Paul
Journal:  J Family Med Prim Care       Date:  2019-06

Review 10.  Osteoporosis and its perspective in Pakistan: A review of evidence and issues for addressing fragility fractures.

Authors:  Aysha Habib Khan; Lena Jafri; Sibtain Ahmed; Shahryar Noordin
Journal:  Ann Med Surg (Lond)       Date:  2018-03-29
View more
  2 in total

1.  FRAX-based intervention thresholds for Pakistan.

Authors:  H Johansson; G Naureen; R Iqbal; L Jafri; A H Khan; M Umer; E Liu; L Vandenput; M Lorentzon; E V McCloskey; J A Kanis; N C Harvey
Journal:  Osteoporos Int       Date:  2021-08-20       Impact factor: 4.507

2.  Reverse engineering the FRAX algorithm: Clinical insights and systematic analysis of fracture risk.

Authors:  Jules D Allbritton-King; Julia K Elrod; Philip S Rosenberg; Timothy Bhattacharyya
Journal:  Bone       Date:  2022-02-28       Impact factor: 4.626

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.